Plasma exchange
Plasma exchange has been studied in 12 papers since 2017: 1 trial and 2 observational studies in people, 5 in animals, 2 reviews; 6 in the past year. The newest paper, Nov 2, 2026: “When the LDL Doesn’t Add Up: A Case-Based Exploration”.
3 new papers in 30 daysSee all 12 papers on plasma exchange
At a glance
The findings reach people, from one lab or study. 6 independent labs in 3 countries; 23 trials, none about aging, 7 with no results posted.
“The procedures were feasible, and the adverse events observed were consistent with known risks of plasma exchange”
1 of its findings points the other way.
- 6 independent labs in 3 countries
- 1 finding against
- 23 trials, none about aging, 7 with no results posted
- Funders: Bilecik Şeyh Edebali Üniversitesi and 6 more
- 1 of 16 findings with company ties
- Human trial1
- Humans2
- Animals5
What did studies of plasma exchange find?
17Studies of plasma exchange measured 17 outcomes, among them liver fibrosis, LDL cholesterol and NSE and GFAP.
Liver fibrosis
upin rats1downin rats1
1 study
Liver fibrosis
upin rats1downin rats1
Plasma exchange increases liver fibrosis in rats (old plasma given to young rats).
Animalsold plasma given to young ratsold plasmaliverthirty daysmales
Plasma exchange decreases liver fibrosis in rats (young plasma given to old rats).
Animalsyoung plasma given to old ratsyoung plasmaliverthirty daysmales
LDL cholesterol
downin humans1
1 study
LDL cholesterol
downin humans1
Plasma exchange is linked with lower LDL cholesterol in humans (Persistent cholestasis; lipid-lowering therapies were discontinued concurrently).
HumansPersistent cholestasis; lipid-lowering therapies were discontinued concurrentlyfemales
NSE and GFAP
no changein mice1
1 study
NSE and GFAP
no changein mice1
Plasma exchange showed no clear effect on NSE and GFAP in mice (PE-treated versus sham-treated APP/PS1 mice).
AnimalsPE-treated versus sham-treated APP/PS1 micewith albumin replacementmonthly
Plasma Aβ
upin mice1
1 study
Plasma Aβ
upin mice1
Plasma exchange increases plasma Aβ in mice (APP/PS1 mice with advanced amyloid pathology).
AnimalsAPP/PS1 mice with advanced amyloid pathologywith albumin replacementmonthly
Microglia burden
downin mice1
1 study
Microglia burden
downin mice1
Plasma exchange decreases microglia burden in mice (APP/PS1 mice with advanced amyloid pathology).
AnimalsAPP/PS1 mice with advanced amyloid pathologywith albumin replacementbrainmonthly
Amyloid plaque burden
downin mice1
1 study
Amyloid plaque burden
downin mice1
Plasma exchange decreases amyloid plaque burden in mice (APP/PS1 mice with advanced amyloid pathology).
AnimalsAPP/PS1 mice with advanced amyloid pathologywith albumin replacementbrainmonthly
Coronary resistance
downin pigs1
1 study
Coronary resistance
downin pigs1
Plasma exchange decreases coronary resistance in pigs (compared with serum fractionate groups during perfusion at 37-48 hours) (0.13 ± 0.05 vs. 0.30 ± 0.13 SF65, 0.69 ± 0.31 SF120 mm Hg/ml/min).
Animalscompared with serum fractionate groups during perfusion at 37-48 hoursunfractionated plasma with plasma filtration and intermittent hemofiltrationheart37-48 hours
Alpha-helix and beta-sheet protein structures
upin rats1
1 study
Alpha-helix and beta-sheet protein structures
upin rats1
Plasma exchange increases alpha-helix and beta-sheet protein structures in rats (measured by infrared spectroscopy-based pattern recognition analysis).
Animalsmeasured by infrared spectroscopy-based pattern recognition analysisyoung plasma30 days
Inflammation
downin rats1
1 study
Inflammation
downin rats1
Plasma exchange decreases inflammation in old rats receiving young plasma.
Animalsin old rats receiving young plasmayoung plasma30 days
necroptosis
downin rats1
1 study
necroptosis
downin rats1
Plasma exchange decreases necroptosis in 24-month-old rats receiving young plasma; shown by RIPK1 and MLKL immunoreactivity.
Animalsin 24-month-old rats receiving young plasma; shown by RIPK1 and MLKL immunoreactivityyoung plasmaliver30 days
All 17Fewer
What is plasma exchange linked with?
1Studies link plasma exchange with adverse events.
Adverse events
upin humans1
1 study
Adverse events
upin humans1
Plasma exchange is associated with adverse events in humans (replacement with young-donor plasma).
Human trialreplacement with young-donor plasmayoung donor plasma16–26 Ln = 12
Has plasma exchange been tested in people?
0 of 23 about agingYes: 1 trial and 2 observational studies in people have been published, and 23 trials are registered.
In trials
Thrombotic thrombocytopenic purpura
Phase 4Status unknown3 trials
Phase 3Completed3 trials
Granulomatosis with polyangiitis
Phase 3Results posted2 trials
Phase 3Results posted2 trials
Phase 3Results posted2 trials
Acute-on-chronic liver failure
Phase 3Status unknown1 trial
All 28Fewer
Readouts due
- Feb 28, 2027
- Feb 28, 2027
Stopped
NCT02647255TerminatedAcute kidney injury
Due to the rarity and rapid progressive course of the disease, patients were less likely to participate in randomization.
NCT04374539TerminatedCoronavirus infection
inability to recruit more patients
Trial sponsors
Company1 trialPhase 364 people
Company1 trialPhase 2/321 people
Company1 trialPhase 212 people
Company1 trialPhase 212 people
Company1 trialEarly phase 112 people
Peking Union Medical College Hospital
1 trialPhase 430 people
1 trialPhase 3704 people
Asian Institute of Gastroenterology, India
1 trialPhase 3130 people